Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John J. Gardner is active.

Publication


Featured researches published by John J. Gardner.


Pediatric Nephrology | 2001

Pediatric acute renal failure: outcome by modality and disease

Timothy E. Bunchman; Kevin D. McBryde; Theresa Mottes; John J. Gardner; Norma J. Maxvold; Patrick D. Brophy

Abstract. Two hundred and twenty-six children who underwent renal replacement therapy (RRT) from 1992 to 1998 were retrospectively reviewed. The mean age, at the onset of RRT, was 74±11.7 months and weight was 25.3±9.7 kg. RRT therapies included hemofiltration (HF; n=106 children for an average of 8.7±2.3 days), hemodialysis (HD; n=61 children for an average of 9.5±1.7 days), and peritoneal dialysis (PD; n=59 children for an average of 9.6±2.1 days). Factors influencing patient survival included: (1) low blood pressure (BP) at onset of RRT (33% survival with low BP, vs 61% with normal BP, vs 100% with high BP; P<0.05), (2) use of pressors anytime during RRT (35% survival in those on pressors vs 89% survival in those not requiring pressors; P<0.01), (3) diagnosis (primary renal failure with a high likelihood of survival vs secondary renal failure; P<0.05), (4) RRT modality (40% survival with HF, vs 49% survival with PD, vs 81% survival with HD; P<0.01 HD vs PD or HF), and (5) pressor use was significantly higher in children on HF (74%) vs HD (33%) or PD (81%; P<0.05 HD vs HF or PD). In conclusion, pressor use has the greatest prediction of survival, rather than RRT modality. Patient survival in children with the need for RRT for ARF is similar to in adults and, as in adults, is best predicted by the underlying diagnosis and hemodynamic stability.


American Journal of Kidney Diseases | 1997

Management of acute renal failure in the pediatric patient: Hemofiltration versus hemodialysis

Norma J. Maxvold; William E. Smoyer; John J. Gardner; Timothy E. Bunchman

Although outcome data for acute renal failure (ARF) in the adult population (analyzed by etiology of ARF, severity of illness, and modality of treatment) are readily available, few similar data exist for the pediatric population. Pediatric survival rate data vary widely, based upon era of analysis, age and size of child, and cause of ARF. Few comparative data are available that address impact by modality chosen to treat ARF. Comparison of 122 children who were treated by hemodialysis (HD; n = 58) versus hemofiltration (HF; n = 64) reveals a combined survival rate of 65%. Survival by modality was higher for HD (83%) than for HF (48%). The major diagnosis treated with HF was sepsis (29/64; 45%), with a survival rate of 31%, whereas the major diagnosis treated with HD (27/58; 46%) was primary renal failure, with a survival rate of 96%. Seventy-one percent of children undergoing HF required pressor support for hypotension, whereas only 24% of those receiving HD needed pressor support (P < 0.01). We conclude that the choice of renal replacement therapy (RRT) modality needs to be determined by the best treatment available. To adequately evaluate therapy measures, further analyses of outcome need to consider those factors that determine choice of RRT and those that affect survival independent of ARF.


American Journal of Kidney Diseases | 2000

Childhood diethylene glycol poisoning treated with alcohol dehydrogenase inhibitor fomepizole and hemodialysis

Patrick D. Brophy; Milton Tenenbein; John J. Gardner; Timothy E. Bunchman; William E. Smoyer

Diethylene glycol (DEG), a commonly used solvent, has been implicated in multiple poisoning deaths, the most recent being the Haitian acetaminophen tragedy. Unlike the more commonly seen ethylene glycol ingestion, little is understood of DEG metabolism or kinetics in humans. This has made the clinical presentation, biochemical correlates, and treatment options unclear. Patients presenting less than 12 hours after DEG ingestion may not show metabolic acidosis, whereas those presenting later may show florid metabolic acidosis. Kinetic data lend support to these observations. We report a case of DEG ingestion in a 17-month-old girl who was managed with activated charcoal, fomepizole (a recently available alcohol dehydrogenase inhibitor), and hemodialysis (HD). Pre-HD and post-HD DEG levels support clearance of DEG with HD.


The Journal of Pediatrics | 1958

Pediculosis capitis in preschool and school children:Control with a shampoo containing gamma benzene hexachloride

John J. Gardner

Summary Forty-seven children affected with pediculosis capitis were treated with a shampoo containing 1 per cent gamma benzene hexachloride. A single shampooing sufficed toeradicate infestation with pediculi and viable nits in all cases. The effect was achieved in a few minutes, the actual contact period of about 4 minutes and the total procedure taking no more time than an average shampoo. Nurses and parents who administeredthe treatment reported it was both simple and pleasant to use, and readily accepted by the patient.


American Journal of Kidney Diseases | 2001

AN-69 membrane reactions are pH-dependent and preventable

Patrick D. Brophy; Theresa A. Mottes; Timothy L. Kudelka; Kevin D. McBryde; John J. Gardner; Norma J. Maxvold; Timothy E. Bunchman


The Journal of Pediatrics | 2004

Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency

Kevin D. McBryde; Timothy L. Kudelka; David B. Kershaw; Patrick D. Brophy; John J. Gardner; William E. Smoyer


Dialysis & Transplantation | 1994

Vascular access for hemodialysis or CVVH(D) in infants and children

Timothy E. Bunchman; John J. Gardner; D. B. Kershaw; Norma J. Maxvold


Dialysis & Transplantation | 1995

A practical approach to continuous hemofiltration in infants and children

William E. Smoyer; J. R. Sherbotie; John J. Gardner; Timothy E. Bunchman


American Journal of Kidney Diseases | 1997

Management of acute renal failure in the pediatric patient

Norma J. Maxvold; William E. Smoyer; John J. Gardner; Timothy E. Bunchman


Advances in Renal Replacement Therapy | 1996

The Infant With Primary Hyperoxaluria and Oxalosis: From Diagnosis to Multiorgan Transplantation

Timothy E. Bunchman; Helen Majors; Greg Majors; John J. Gardner; Joan DeVee; Evelyn M. Dennerll; Joanna L. Hesford; Cynthia L. Mitchell; Jeffrey D. Punch

Collaboration


Dive into the John J. Gardner's collaboration.

Top Co-Authors

Avatar

Timothy E. Bunchman

Virginia Commonwealth University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kevin D. McBryde

Children's National Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Greg Majors

University of Michigan

View shared research outputs
Researchain Logo
Decentralizing Knowledge